Cardiovascular Systems Misses Q2 EPS by 5c
Cardiovascular Systems (CSII) reported Q2 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $61.5 million versus the consensus estimate of...
Strong Buy
or
Cardiovascular News & Analysis
-
-
Cardiovascular earnings missed by $0.05, revenue fell short of estimates
Investing.com - Cardiovascular (NASDAQ: CSII) reported second quarter EPS of $-0.20, $0.05 worse than the analyst estimate of $-0.15. Revenue for the quarter came in at $61.45M versus the...
-
Cardiovascular Needle Market will reach to USD 148.8 billion by 2030 : GreyViews
Pune India, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and...
-
Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition
Shockwave Medical Inc (NASDAQ: SWAV) has agreed to acquire Neovasc Inc (NASDAQ: NVCN) for an upfront cash payment of $27.25 per share, corresponding to an enterprise value of approximately...
-
Heart Rate Variability – What To Know About This Biometric Most Fitness Trackers Measure
Your heart beats around 100,000 times every day. Heart rate is a key marker of cardiovascular activity and an important vital sign. But your pulse is not as steady as a precision clock...
-
Cardiovascular Systems Tops Q3 EPS by 3c
Cardiovascular Systems (NASDAQ:CSII) reported Q3 EPS of ($0.25), $0.03 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.2 million versus the consensus...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
